PATENT CLAIM ANALYSIS

Application Number: 16049180
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "044000"]

Abstract:
This document provides methods and materials related to treating glaucoma, ocular hypertension, cardiovascular diseases, and renal diseases. For example, this document provides isolated nucleic acid molecules and viral vectors (e.g., lentiviral vectors) containing isolated nucleic acid molecules. Methods for reducing intraocular pressure as well as symptoms and progression of cardiovascular and renal diseases also are provided.

Claim (Index 1):
A method for treating a mammal having glaucoma or elevated intraocular pressure, said method comprising administering a viral vector to an eye of said mammal under conditions effective to reduce intraocular pressure of said eye, wherein said viral vector comprises a nucleic acid encoding a polypeptide having cyclooxygenase-2 activity.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13624383', '14510921', '12298431', '15187471', '11601208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8115575648190444
- 35 USC 102 Novelty (BERT): 0.6251296128837861
- Combined Prediction Score: 0.7929147696255185
- Mean Citation Score: 537.6121499999998
- Max Citation Score: 609.52136
- Similarity Product: 511.26049390111433

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test